VanEck Biotech ETF
BBH
BBH
84 hedge funds and large institutions have $67.4M invested in VanEck Biotech ETF in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.38% less ownership
Funds ownership: 20.24% → 17.86% (-2.4%)
23% less capital invested
Capital invested by funds: $87.5M → $67.4M (-$20.1M)
Holders
84
Holding in Top 10
–
Calls
$777K
Puts
$689K
Top Buyers
| 1 | +$1.98M | |
| 2 | +$1.26M | |
| 3 | +$1.16M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$844K |
| 5 |
VF
Virtu Financial
New York
|
+$655K |
Top Sellers
| 1 | -$3.91M | |
| 2 | -$3.34M | |
| 3 | -$1.21M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$526K |
| 5 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$511K |